Ilijas Jelcic

Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Objective Specific human leucocyte antigen (HLA) alleles are not only associated with higher risk to develop multiple sclerosis (MS) and other autoimmune diseases, but also with the severity of various viral and bacterial infections. Here, we analyzed the most specific biomarker for MS, that is, the polyspecific intrathecal IgG antibody production against measles, rubella, and varicella zoster virus (MRZ reaction), for possible HLA associations in MS. Methods We assessed MRZ reaction from 184 Swiss patients with MS and clinically isolated syndrome (CIS) and 89 Swiss non‐MS/non‐CIS control patients, and performed HLA sequence‐based typing, to check for associations of positive MRZ reaction with the most prevalent HLA alleles. We used a cohort of 176 Swedish MS/CIS patients to replicate significant findings. Results Whereas positive MRZ reaction showed a prevalence of 38.0% in MS/CIS patients, it was highly specific (97.7%) for MS/CIS. We identified HLA‐DRB1*15:01 and other tightly linked alleles of the HLA‐DR15 haplotype as the strongest HLA‐encoded risk factors for a positive MRZ reaction in Swiss MS/CIS (odds ratio [OR], 3.90, 95% confidence interval [CI] 2.05–7.46, p adjusted = 0.0004) and replicated these findings in Swedish MS/CIS patients (OR 2.18, 95%‐CI 1.16–4.02, p adjusted = 0.028). In addition, female MS/CIS patients had a significantly higher probability for a positive MRZ reaction than male patients in both cohorts combined ( p adjusted <0.005). Interpretation HLA‐DRB1*15:01, the strongest genetic risk factor for MS, and female sex, 1 of the most prominent demographic risk factors for developing MS, predispose in MS/CIS patients for a positive MRZ reaction, the most specific CSF biomarker for MS. ANN NEUROL 2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Thorsten Buch

-

SWITZERLAND
View details

Pernilla Stridh

Karolinska Institutet

SWEDEN
View details

Ingrid Kockum

Research group leader at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Eliane Marti

University of Bern

SWITZERLAND
View details

Waldemar Brola

Jan Kochanowski University

POLAND
View details

Tibor Kovács

Associate Professor

Semmelweis University

HUNGARY
View details

Benjamin Vlad

Jena University Hospital

GERMANY
View details

Clemens Warnke

University Hospital Bonn

GERMANY
View details

Ettore Beghi

Head Laboroatory of neurological Disorders

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.